Cosmetic Surgery Products : Market Research Report

Cosmetic Surgery Products

Published: Sep. 1, 2008 - 261 Pages

INTRODUCTION
I. EXECUTIVE SUMMARY
II. MARKET ENVIRONMENT
General
Demographic Trends
Macroeconomic Outlook
Consumer Spending Outlook
Physicians & Facility Trends
Spa Industry Outlook
Competitive Product Trends
Medical Product Market Outlook
Regulatory Issues
International Activity
III. COSMETIC PROCEDURES
General
Surgical: Reshaping; Lifts & Tucks; Implants; Liposuction; Other Surgical
Nonsurgical: Injections; Laser Dermal Resurfacing; Dermal Resurfacing; Other Nonsurgical
IV. PRODUCTS
General
Equipment: Lasers & Other Light-Based Systems; Microdermabrators; Consumables; Liposuction Equipment; Other Equipment
Injectables: Botulinum Toxin; Tissue Fillers; Other Injectables
Implants: Breast Implants; Other Implants
Wound Care Disposables: Bandages & Dressings; Wound Closures; Other Wound Care
Other Cosmetic Surgery Products
V. RAW MATERIALS
General
Biological Materials: Microbial Extracts; Collagen; Other
Polymers
Other
VI. INDUSTRY STRUCTURE
General
Market Share: Allergan; Mentor; Medicis; Other Market Leaders
Industry Restructuring
Competitive Strategies
Research & Development
Cooperative Agreements
Marketing
Company Profiles: Advanced Cosmetic Intervention Incorporated, see BioForm Medical Incorporated; Alcon Incorporated; Allergan Incorporated; Artes Medical Incorporated; BioForm Medical Incorporated; Candela Corporation; Covidien Limited; Cutera Incorporated; Cynosure Incorporated; Dectro International; DermaMed USA Incorporated; Diamond International Corporation Pty Limited; Dynatronics Corporation; Ethicon Incorporated, see Johnson & Johnson; ExcellaDerm Corporation; Fascia Biosystems LLC; Gamma Biologicals Incorporated, see Immucor; Genesis Biosystems Incorporated; Genzyme Corporation; Groupe Corneal Laboratoires SA, see Allergan; Hoya Corporation; Immucor Incorporated; Implantech Associates Incorporated; Inolase Limited, see Candela Corporation; IntegreMed LLC; IRIDEX Corporation; Johnson & Johnson; Kendall Company, see Covidien Limited; Kinetic Concepts Incorporated; Laserscope, see IRIDEX Corporation; LifeCell Corporation, see Kinetic Concepts; LipoSonix Incorporated, see Medicis Pharmaceutical; Lumenis Limited; Medicis Pharmaceutical Corporation; Mentor Corporation; Palomar Medical Technologies Incorporated; Q-Med AB; Sanofi-Aventis; Smith & Nephew plc; Solstice Neurosciences Incorporated; Syneron Medical Limited; 3M Company; Tissue Science Laboratories plc, see Covidien Limited; United States Surgical, see Covidien Limited
Other Companies Mentioned in the Study
LIST OF TABLES
SECTION I -- EXECUTIVE SUMMARY: Summary Table
SECTION II -- MARKET ENVIRONMENT: 1 Population & Households; 2 Macroeconomic Indicators; 3 Personal Consumption Expenditures; 4 Physicians & Facilities; 5 Spa Facilities by Type; 6 Medical Products & Equipment Demand
SECTION III --- COSMETIC PROCEDURES: 1 Cosmetic Procedures Demand by Type; 2 Surgical Cosmetic Procedures Demand by Type; 3 Cosmetic Reshaping Procedures Demand by Type; 4 Cosmetic Lift & Tuck Demand by Type; 5 Cosmetic Implant Procedures Demand by Type; 6 Liposuction Procedures Demand; 7 Other Surgical Cosmetic Procedures Demand; 8 Nonsurgical Cosmetic Procedures Demand by Type; 9 Cosmetic Injection Demand by Type; 10 Botulinum Toxin Injection Demand; 11 Soft Tissue Filler Injection Demand by Type; 12 Other Injection Demand; 13 Laser Treatment Demand by Type; 14 Dermal Resurfacing Treatments Demand by Type; 15 Other Nonsurgical Cosmetic Treatment Demand
SECTION IV -- PRODUCTS: 1 Cosmetic Surgery Products Demand by Type; 2 Cosmetic Equipment Demand by Type; 3 Cosmetic Laser & Other Light-based Equipment Demand by Type; 4 Microdermabrator Demand; 5 Cosmetic Surgery Consumables Demand; 6 Liposuction Equipment Demand; 7 Other Cosmetic Surgery Equipment Demand; 8 Cosmetic Surgery Injectables Demand; 9 Botulinum Toxin Demand in Cosmetic Surgery; 10 Tissue Fillers Demand in Cosmetic Surgery; 11 Hyaluronic Acid Fillers Demand in Cosmetic Surgery; 12 Collagen Fillers Demand in Cosmetic Surgery; 13 Other Tissue Fillers Demand in Cosmetic Surgery; 14 Other Injectables Demand in Cosmetic Surgery; 15 Cosmetic Surgery Implants Demand; 16 Breast Implants Demand; 17 Other Cosmetic Implants Demand by Type; 18 Wound Closures Demand in Cosmetic Surgery; 19 Bandages & Dressings Demand in Cosmetic Surgery; 20 Wound Closures Demand in Cosmetic Surgery; 21 Other Wound Care Disposables Demand in Cosmetic Surgery; 22 Other Cosmetic Surgery Products Demand
SECTION V -- RAW MATERIALS: 1 Cosmetic Surgery Raw Material Demand; 2 Biological Materials Demand in Cosmetic Surgery Products; 3 Polymers Demand in Cosmetic Surgery Products; 4 Other Raw Material Demand in Cosmetic Surgery Products
SECTION VI -- INDUSTRY STRUCTURE: 1 US Cosmetic Surgery Product Sales by Company, 2007; 2 Selected Acquisitions & Divestitures; 3 Selected Cooperative Agreements
LIST OF CHARTS
SECTION II -- MARKET ENVIRONMENT: 1 Global Cosmetic Surgery Product Demand, 2007
SECTION III -- COSMETIC PROCEDURES: 1 Cosmetic Procedures Demand by Type, 1997-2017; 2 Surgical Cosmetic Procedures Demand by Type, 2007; 3 Nonsurgical Cosmetic Procedures Demand by Type, 1997-2017; 4 Soft Tissue Filler Injection Demand by Type, 1997-2017
SECTION IV -- PRODUCTS: 1 Cosmetic Surgery Products Demand by Type, 1997-2017
SECTION VI -- INDUSTRY STRUCTURE: 1 US Cosmetic Surgery Product Market Share by Company, 2007

Abstract

Demand to grow more than 8% annually through 2012
Demand for cosmetic surgery products in the US is forecast to increase 8.1 percent per year to $2.5 billion in 2012, based on increases in cosmetic surgery procedures, which are forecast to reach 16 million over the same time period. America’s obsession with a youthful appearance is longstanding, and is unlikely to subside anytime soon. This coupled with an aging population, a greater societal acceptance of cosmetic surgery, and an increasingly competitive work force will bode well for the cosmetic surgery industry. Due to much more busy lifestyles, less invasive cosmetic surgery procedures and products (such as injections, laser dermal resurfacing and microdermabrasion) that result in little or no recovery time will experience the best opportunities. However, demand for surgical products will continue to be strong in some areas, such as implants, where there are no notable alternatives.

Lasers, microdermabrasion machines will offer steady equipment gains
Equipment was the largest product type in 2007, with one-third of the market. Demand will be driven as a wider variety of practitioners are expected to increasingly offer cosmetic options as these procedures are generally “out-of-pocket” expenses and thus avoid the need to deal with insurance companies. The development of easier-to-use and safer equipment will also continue to open up strong opportunities in other end-users such as beauty salons and spas. Among equipment types, microdermabrasion machines and laser and other light-based systems will continue to achieve steady growth.

Please Note: Freedonia requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Cosmetic Surgery Products

Table of Contents

Abstract